Oct 132016
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – Inspyr Therapeutics, Inc. (OTC:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced today the appointment of Richard Buller, M.D., Ph.D.… => Read more

Inspyr Therapeutics appoints Dr Rich Buller to its Board of Directors

From:: Inspyr Therapeutics appoints Dr Rich Buller to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: